United States · Industrial & Consumer Products · USD (Millions) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Repare Therapeutics Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -46.63% | -1.28% | -1.3% | -1.31% | -1.33% | -1.35% |
|---|---|---|---|---|---|---|
| ROA | -39.35% | -1.09% | -1.09% | -1.09% | -1.09% | -1.09% |
| Total Assets | $176.51M | $176.51M | $176.51M | $176.51M | $176.51M | $176.51M |
| Net Income | -$84.69M | -$1.92M | -$1.92M | -$1.92M | -$1.92M | -$1.92M |